---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-011098"
form_type: "8-K"
ticker: "INTS"
cik: "0001567264"
company_name: "INTENSITY THERAPEUTICS, INC."
filed_at: "2024-02-07T23:59:59+00:00"
generated_at: "2026-06-06T06:57:12.030082+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Intensity Therapeutics adopts incentive compensation plan for salaried employees and executive officers

## Summary
- Plan adopted Feb 6, 2024, effective retroactively to Oct 1, 2023, for all salaried employees including executive officers.
- Bonuses based on Performance Goals tied to individual performance and company milestones; CEO sets goals, Board approves.
- Award formula uses percentage of salary multiplied by weighted percentages for individual and company performance; leadership accountability weighting varies by level.
- Payments made on or about March 31 of following year; subject to clawback policy adopted Oct 23, 2023.

## SEC filing metadata
- accession: 0001213900-24-011098
- form_type: 8-K
- ticker: INTS
- cik: 0001567264
- company_name: INTENSITY THERAPEUTICS, INC.
- filed_at: 2024-02-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1567264/000121390024011098/0001213900-24-011098-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1567264/000121390024011098/ea193020-8k_intensity.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-011098
- JSON: https://secwatch.observer/filing/0001213900-24-011098.json
- Plain text: https://secwatch.observer/filing/0001213900-24-011098.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.